title: Bevacizumab to treat complicated liver vascular malformations in hereditary hemorrhagic telangiectasia: a word of caution.
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Buscarini
authors.forename: Guido
authors.initials: G
authors.lastname: Manfredi
authors.forename: Alessandro
authors.initials: A
authors.lastname: Zambelli
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D006439:Hemodynamics; D006801:Humans; D008107:Liver Diseases / Q000188:drug therapy*; D013683:Telangiectasia, Hereditary Hemorrhagic / Q000188:drug therapy*; D016896:Treatment Outcome; D054079:Vascular Malformations / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab